What the institutional money is doing on GILD right now — dark pool, options positioning, and where the news and the money disagree. Free.
News highlights sector tailwinds, but institutional traders are net-short via options (more puts than calls) and today's flow is defensive, suggesting skepticism about Gilead's ability to win in that growth.
Neutral reporting on ETF mechanics; money signals remain defensive (put-heavy, low squeeze pressure), indicating lukewarm institutional conviction in biotech broadly.
News is bullish on pipeline catalysts and financials, but institutions are accumulating via dark pools while hedging with puts—a classic 'buy the dip' posture that suggests they see near-term risk despite long-term upside.
Positive framing of ETF options, but underlying money signals (defensive puts, low squeeze) suggest institutional caution is not reflected in this educational comparison.
Operational progress is positive, but money positioning remains defensive (put-heavy, high dark-pool accumulation without corresponding call strength), hinting that institutions are not yet pricing in this win.
A divergence is when the news narrative and the institutional money flow point in opposite directions — a bearish headline while large call premium is bought, or heavy dark-pool selling under a bullish story. It signals the crowd and the desks may disagree.
Dark-pool volume — The share of trading done off-exchange, where institutions move size quietly. Well above ~40% means big players are active.
Max pain — The price where the most options expire worthless — positioning often gravitates toward it near expiry.
Call wall / Put floor — Strikes with the heaviest call/put open interest — they often act as short-term resistance and support.
Put/Call ratio — Below ~0.7 leans bullish (more calls); above ~1 leans defensive (more puts).
